Ecuador has paid around US$53 million to US pharmaceuticals group Merck Sharpe & Dohme to settle an investment treaty award that held the state liable for a denial of justice.
Read the full story at ADR/ODR Institution Watch →Get dispute resolution news like this, personalised to your topics — free.
Sign up — it's free Log in